Cargando…
TP53 gene mutations and protein accumulation in primary vaginal carcinomas.
Primary carcinomas from 46 patients were screened for TP53 alterations. Immunohistochemistry demonstrated nuclear TP53 protein accumulation in 22 (48%) cases using the polyclonal CM1 antiserum, whereas 15 (33%) cases showed positive nuclear staining with the mononuclear antibody PAb 1801. Constant d...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034131/ https://www.ncbi.nlm.nih.gov/pubmed/7599041 |
_version_ | 1782136989755113472 |
---|---|
author | Skomedal, H. Kristensen, G. Helland, A. Nesland, J. M. Kooi, S. Børresen, A. L. Holm, R. |
author_facet | Skomedal, H. Kristensen, G. Helland, A. Nesland, J. M. Kooi, S. Børresen, A. L. Holm, R. |
author_sort | Skomedal, H. |
collection | PubMed |
description | Primary carcinomas from 46 patients were screened for TP53 alterations. Immunohistochemistry demonstrated nuclear TP53 protein accumulation in 22 (48%) cases using the polyclonal CM1 antiserum, whereas 15 (33%) cases showed positive nuclear staining with the mononuclear antibody PAb 1801. Constant denaturant gel electrophoresis (CDGE) was used to screen 27 of the vaginal carcinomas for mutations in the conserved regions of the TP53 gene (exons 5-8). Six of these tumours (22%) contained mutations: four were found in exon 5 and two in exon 8. A total of 50% of the primary vaginal carcinomas carried a TP53 alteration. These results indicate that TP53 abnormalities may be involved in the development of these tumours. However, there was no significant association between TP53 abnormalities and survival. IMAGES: |
format | Text |
id | pubmed-2034131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1995 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20341312009-09-10 TP53 gene mutations and protein accumulation in primary vaginal carcinomas. Skomedal, H. Kristensen, G. Helland, A. Nesland, J. M. Kooi, S. Børresen, A. L. Holm, R. Br J Cancer Research Article Primary carcinomas from 46 patients were screened for TP53 alterations. Immunohistochemistry demonstrated nuclear TP53 protein accumulation in 22 (48%) cases using the polyclonal CM1 antiserum, whereas 15 (33%) cases showed positive nuclear staining with the mononuclear antibody PAb 1801. Constant denaturant gel electrophoresis (CDGE) was used to screen 27 of the vaginal carcinomas for mutations in the conserved regions of the TP53 gene (exons 5-8). Six of these tumours (22%) contained mutations: four were found in exon 5 and two in exon 8. A total of 50% of the primary vaginal carcinomas carried a TP53 alteration. These results indicate that TP53 abnormalities may be involved in the development of these tumours. However, there was no significant association between TP53 abnormalities and survival. IMAGES: Nature Publishing Group 1995-07 /pmc/articles/PMC2034131/ /pubmed/7599041 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Skomedal, H. Kristensen, G. Helland, A. Nesland, J. M. Kooi, S. Børresen, A. L. Holm, R. TP53 gene mutations and protein accumulation in primary vaginal carcinomas. |
title | TP53 gene mutations and protein accumulation in primary vaginal carcinomas. |
title_full | TP53 gene mutations and protein accumulation in primary vaginal carcinomas. |
title_fullStr | TP53 gene mutations and protein accumulation in primary vaginal carcinomas. |
title_full_unstemmed | TP53 gene mutations and protein accumulation in primary vaginal carcinomas. |
title_short | TP53 gene mutations and protein accumulation in primary vaginal carcinomas. |
title_sort | tp53 gene mutations and protein accumulation in primary vaginal carcinomas. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034131/ https://www.ncbi.nlm.nih.gov/pubmed/7599041 |
work_keys_str_mv | AT skomedalh tp53genemutationsandproteinaccumulationinprimaryvaginalcarcinomas AT kristenseng tp53genemutationsandproteinaccumulationinprimaryvaginalcarcinomas AT hellanda tp53genemutationsandproteinaccumulationinprimaryvaginalcarcinomas AT neslandjm tp53genemutationsandproteinaccumulationinprimaryvaginalcarcinomas AT koois tp53genemutationsandproteinaccumulationinprimaryvaginalcarcinomas AT børresenal tp53genemutationsandproteinaccumulationinprimaryvaginalcarcinomas AT holmr tp53genemutationsandproteinaccumulationinprimaryvaginalcarcinomas |